Nicholas Jason Singer is a director of Eterna Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
SC 13G/A
Eterna Therapeutics Inc.
19 Jan 24
SC 13G/A
Eterna Therapeutics Inc.
8 Sep 23
SC 13G
Comera Life Sciences Holdings, Inc.
24 Aug 23
SC 13D/A
Eterna Therapeutics Inc.
26 Jul 23
SC 13D
Eterna Therapeutics Inc.
20 Dec 22
4
Eterna Therapeutics Inc.
6 Dec 22
4
Brooklyn ImmunoTherapeutics, Inc.
3 Aug 22
3
Brooklyn ImmunoTherapeutics, Inc.
7 Jun 22
4
OTR Acquisition Corp.
20 May 22
4
OTR Acquisition Corp.
10 May 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Dec 22 | ERNA Eterna Therapeutics | Common Stock | Buy | Acquire P | Yes | No | 3.28 | 212,464 | 696.88 k | 266,214 |
2 Dec 22 | ERNA Eterna Therapeutics | Common Stock | Buy | Acquire P | Yes | No | 3.28 | 70,822 | 232.30 k | 121,822 |
2 Dec 22 | ERNA Eterna Therapeutics | Warrants Common Stock, par value $0.005 per share | Buy | Acquire P | Yes | No | 0.125 | 424,928 | 53.12 k | 424,928 |
2 Dec 22 | ERNA Eterna Therapeutics | Warrants Common Stock, par value $0.005 per share | Buy | Acquire P | Yes | No | 0.125 | 141,644 | 17.71 k | 141,644 |